The U. S. FDA and CDC U. S. Sees Early Signal Between Pfizer’s Bivalent COVID Vaccine and Stroke

A protective tracking formula has reported that the updated COVID-19 vaccine from U. S. drugmaker Pfizer Incorporated and its German partner BioNTech could be linked to a type of stroke in the elderly, according to initial data analyzed by U. S. health authorities. U. S.

The U. S. Centers for Disease Control and Prevention (CDC)The U. S. Food and Drug Administration (FDA) said Friday, Jan. 13, that a CDC vaccine database discovered an imaginable protective factor in which other people 65 and older were more likely to have an ischemic stroke 21 days after receiving the bivalent Pfizer/BioNTech injection. compared to days 22 to 44.

An ischemic stroke, also known as cerebral ischemia, occurs through blockages in the arteries that carry blood to the brain.

The FDA and CDC said other giant studies, the CDC’s vaccine adverse event reporting system, other countries’ databases and Pfizer-BioNTech databases have reported on this protection issue, adding that it requires further investigation.

“While the totality of information recently suggests that the sign in VSD (Vaccine Safety Data Link) represents a real clinical risk, it is important to share this information with the public,” said the government of fitness .

Pfizer and BioNTech said in a statement that they were informed of limited reports of ischemic strokes in others 65 and older after vaccination with their updated vaccine.

“Neither Pfizer nor BioNTech, nor the CDC nor the FDA have observed effects on many other surveillance systems in the U. S. “There is no evidence to conclude that ischemic stroke is related to the use of corporate COVID-19 vaccines. “the corporations said.

This protective factor has not been known with Moderna’s bivalent vaccine, and CDC and FDA continue to advocate that children six months and older keep up with their COVID-19 vaccination Rappler. com.

Leave a Comment

Your email address will not be published. Required fields are marked *